{
    "code": "60000985",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000985",
    "time": "2020-02-26 09:58:55",
    "許可證字號": "衛部菌疫輸字第000985號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "109\/09\/10",
    "發證日期": "104\/09\/10",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000098500",
    "中文品名": "薩溫珂&#174;凍晶注射劑400毫克",
    "英文品名": "Sylvant&#174; Powder for Concentrate for Solution for Infusion 400mg",
    "適應症": "適用於治療人類免疫不全病毒(HIV)陰性及人類皰疹病毒-8(HHV-8)陰性的多發性Castleman氏病(Multicentric Castleman's Disease(MCD))患者。",
    "劑型": "243凍晶注射劑",
    "包裝": "玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/09\/10",
    "主成分略述": "Siltuximab",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0216000  CILAG AG",
            "製造廠廠址": "HOCHSTRASSE 201, 8200 SCHAFFHAUSEN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FIE0080000  JANSSEN SCIENCES IRELAND UC",
            "製造廠廠址": "BARNAHELY, RINGASKIDDY, CO.CORK, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FNL0059000  JANSSEN BIOLOGICS B.V.",
            "製造廠廠址": "EINSTEINWEG 101, 2333 CB LEIDEN, THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200081300",
            "成分名稱": "Siltuximab",
            "含量描述": "(Nominal amount 100mg\/vial)",
            "含量": "420.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Sylvant 400mg 產品外觀-108-03-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000985&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "薩溫珂凍晶注射劑(USPI May 2018_v1801)-107-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000985&Seq=005&Type=9"
        },
        {
            "title": "薩溫珂凍晶注射劑400毫克-標籤-106-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000985&Seq=011&Type=8"
        },
        {
            "title": "薩溫珂凍晶注射劑400毫克-外盒-106-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000985&Seq=010&Type=8"
        },
        {
            "title": "03_0621-1.06.2_Siltuximab 400mg 中文小標籤-106-08-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000985&Seq=007&Type=8"
        },
        {
            "title": "2015-12-23 Sylvant 400mg 中文小標籤 with TFDA stamp-104-12-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000985&Seq=006&Type=8"
        }
    ]
}